Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Xiaotang (Jessica) Ma, Ph.D
Sr. Research Investigator
Bristol-Myers Squibb
Poster(s):
(M-070) Model Informed Drug Development (MIDD) Approach to Support Elzovantinib (TPX-022) Recommended Phase 2 Dose
Monday, November 11, 2024
7:00 AM – 5:00 PM
MST